𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Upregulation of Wilms' tumor gene 1 (WT1) in desmoid tumors

✍ Scribed by Saeid Amini Nik; Peter Hohenstein; Ali Jadidizadeh; Kim Van Dam; Adriana Bastidas; Rachel L. Berry; Charles E. Patek; Bernadette Van der Schueren; Jean-Jacques Cassiman; Sabine Tejpar


Publisher
John Wiley and Sons
Year
2004
Tongue
French
Weight
287 KB
Volume
114
Category
Article
ISSN
0020-7136

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

Desmoid tumors (aggressive fibromatosis) are locally invasive soft tissue tumors in which β‐catenin/TCF3 mediated Wnt signaling is activated. More than 80% of desmoid tumors contain activating mutations in β‐catenin. It has been shown that the Wnt signaling pathway interacts with Wilms' tumor gene 1 (WT1) in normal kidney development and plays a role in the genesis of some Wilms' tumors. About 15% of Wilms' tumors contain WT1 mutations and of these, about 50% contain β‐catenin mutations. This overlap in mutation pattern of WT1 and β‐catenin in Wilms' tumor suggests that these 2 genes may collaborate in the genesis of a subset of Wilms' tumors. To investigate whether this hypothesis could be extended to other Wnt‐dependent tumor types, we searched for WT1 mutations and studied WT1 expression in β‐catenin mutant desmoid tumors. We investigated the expression of WT1 mRNA and protein in desmoid tumors. Medium to high abundant levels of WT1 mRNA were detected by TaqMan quantitative PCR in all tested desmoids cells, whereas adjacent normal fibroblasts showed less expression of WT1. Western blot analysis and immunohistochemistry confirmed this overexpression at the protein level. A mutational screen of the WT1 zinc‐finger region by sequence analysis did not identify any mutations. Finally, we investigated a possible role of β‐catenin on WT1 regulation and vice versa. Overexpression of different β‐catenin mutants in the HEK293T cell line did not modulate WT1 promoter activity and WT1 did not affect β‐catenin /TCF transcriptional activity in this cell line. These results show that the wild‐type WT1 gene is strongly overexpressed in β‐catenin mutant desmoid tumors and may play a role in tumorigenesis of desmoid tumors, similar to what has been suggested in some epithelial malignancies. © 2004 Wiley‐Liss, Inc.


📜 SIMILAR VOLUMES


Analysis of the wilms tumor suppressor g
✍ Raymond Rackley; Graham Casey; Xiao-Ian Zhao; David W. Miller; Bryan R. G. Willi 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 243 KB

## Abstract This study reports on the evaluation of the Wilms tumor suppressor gene __WT1__ in 14 endometrial carcinomas. Despite the fact that several endometrial carcinomas were shown to express __WT1__, we were unable to demonstrate mutations in the __MT1__ zinc finger region, suggesting that __

Overexpression of the Wilms' tumor gene
✍ Yusuke Oji; Shinichiro Miyoshi; Hajime Maeda; Seiji Hayashi; Hiroya Tamaki; Shin 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 French ⚖ 627 KB

## Abstract Expression of the Wilms' tumor gene __WT1__ in __de novo__ lung cancer was examined using quantitative real‐time RT‐PCR and immunohistochemistry. Overexpression of the __WT1__ gene was detected by RT‐PCR in 54/56 (96%) __de novo__ non‐small cell lung cancers examined and confirmed by de

Constitutive expression of the Wilms tum
✍ Christine E. Campbell; Nishi P. Kuriyan; Raymond R. Rackley; Michael J. Caulfiel 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 French ⚖ 380 KB 👁 2 views

The expression of the Wilms tumor suppressor gene WT1 is largely restricted to elements of the developing urogenital system. In the fetal kidney, WT1 transcripts are present at low levels in the condensing mesenchyme and at much higher levels in differentiating glomerular epithelium and are not dete